Biography:
Dr Lekshmi R Nath is currently working as an Assistant professor in the Department of Pharmacognosy at Amrita school of Pharmacy, Kochi, India. She obtained her M.Pharm in Pharmacognosy from Rajiv Gandhi University of Health Sciences, India in 2008. After this, she joined Rajiv Gandhi Centre for Biotechnology, Kerala, India, and received her Doctorate in Biotechnology in 2016. Her PhD findings on hepatocellular carcinoma recently received four international patents, US, Canadian, Japan and South Korean Patent ( WO 2017208254 A1, “Uttroside B And Derivatives Thereof As Therapeutics For Hepatocellular Carcinoma”. The FDA has recently granted an orphan drug designation to the small molecule chemotherapeutic uttroside–B against hepatocellular carcinoma. Q BioMed, a biopharmaceutical company has already started a clinical trial for uttroside B against Hepatocellular carcinoma. She has more than 13 years of research experience with over 30 publications. She has published several publications in many renowned International Journals including Scientific Reports, Plose ONE, RSC Advance, Frontiers in Microbiology etc. Her key research interest includes phytomedicine and Hepatocellular carcinoma, liposomal drug delivery etc
Title : Phytochemical-based nanoformulation against Hepatocellular carcinoma